Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.

Archives of pathology & laboratory medicine - 1 Jun 2017

Garcia Elizabeth P, Minkovsky Alissa, Jia Yonghui, Ducar Matthew D, Shivdasani Priyanka, Gong Xin, Ligon Azra H, Sholl Lynette M, Kuo Frank C, MacConaill Laura E, Lindeman Neal I, Dong Fei

Abstract excerpt

CONTEXT: - The analysis of somatic mutations across multiple genes in cancer specimens may be used to aid clinical decision making. The analytical validation of targeted next-generation sequencing panels is important to assess accuracy and limitations. OBJECTIVE: - To report the development and validation of OncoPanel, a custom targeted next-generation sequencing assay for cancer. DESIGN: - OncoPanel was designed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Comparative Genomic Hybridization
Share to Formaldehyde

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to In Situ Hybridization, Fluorescence

Share to Neoplasms

Share to Nucleophosmin

Share to Paraffin Embedding

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 28557599
DOI: 10.5858/arpa.2016-0527-OA

Genes

FLT3
IGH
NPM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.PMID 28557599Read ↗

A targeted next-generation sequencing panel for identification of clinically relevant mutation profiles in solid tumoursSemantic proximity Read ↗

Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions.Semantic proximity Read ↗

Validation of a next-generation sequencing assay for clinical molecular oncology.Semantic proximity Read ↗

Clinical and Technical Validation of OncoIndx® Assay – A Comprehensive Genome Profiling Assay for Pan-Cancer InvestigationsSemantic proximity Read ↗

Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.Semantic proximity Read ↗

Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.Semantic proximity Read ↗

Validation and Clinical Application of ONCOaccuPanel for Targeted Next-Generation Sequencing of Solid Tumors.Semantic proximity Read ↗

EXaCT-2: An augmented and customizable oncology-focused whole exome sequencing platformSemantic proximity Read ↗

Automated next-generation profiling of genomic alterations in human cancers.Semantic proximity Read ↗

Analytical Validation and Clinical Utilization of the Oncomine Comprehensive Assay Plus Panel for Comprehensive Genomic Profiling in Solid TumorsSemantic proximity Read ↗

Multicenter In-House Evaluation of an Amplicon-Based Next-Generation Sequencing Panel for Comprehensive Molecular Profiling.Semantic proximity Read ↗

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.